Program
Anaprazole Sodium enteric-coated tablet
Also written as “[14C]-Anaprazole Sodium enteric-coated capsule”.
Its studies are mostly in Hepatic Insufficiency, led by Sihuan Pharmaceutical Holdings Group.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Sihuan Pharmaceutical Holdings Group | 52 open or running | phase 4since Jan 7, 2026 | Jun 30, 2020 | Feb 19, 2027phase 3 · NCT07606833 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jun 30, 2020First studies: 2 phase 1 studies in Healthy VolunteersFirst studyNCT04471922, NCT04466748
- Jul 15, 2020Phase 1 study in Healthy Male VolunteersNCT04476394 · 6 enrolled
- Jan 7, 2026Phase 4 study in Hepatic InsufficiencyNCT07345689 · 60 planned · China
- May 19, 2026Phase 3 study in HELICOBACTER PYLORI INFECTIONSNCT07606833 · 556 planned · China
Ahead
- Feb 19, 2027Primary completion: phase 3 study in HELICOBACTER PYLORI INFECTIONSNCT07606833
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 5 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07606833HELICOBACTER PYLORI INFECTIONS · China | 3 | Not yet recruiting | Feb 19, 2027 | 556 |
| NCT07345689Hepatic Insufficiency · China | 4 | Not yet recruiting | Oct 30, 2026 | 60 |
| NCT04476394Healthy Male Volunteers | 1 | UNKNOWN | Sep 30, 2020 | 6 |
| NCT04471922Healthy Volunteers · China | 1 | Completed | Mar 28, 2019 | 45 |
| NCT04466748Healthy Volunteers | 1 | Completed | Dec 29, 2015 | 36 |
How it is read
Names in the registry
- “Anaprazole Sodium enteric-coated tablet”, 4 entries
- “[14C]-Anaprazole Sodium enteric-coated capsule”, 1 entry
Conditions, from the studies’ own filings
- Hepatic Insufficiency, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.